Abeta 1-40 anticorps (C-Term) (Cy3)

N° du produit ABIN729331

Détail du produit anti-Abeta 1-40 anticorps (Cy3)

Antigène: Abeta 1-40 (Amyloid beta 1-40 (Abeta 1-40))

Épitope: C-Term

Reactivité: Humain, Rat, Souris, Poulet, Boeuf (Vache), Chien, Porc

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Abeta 1-40 est conjugé à/à la Cy3

Application: Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Réactivité croisée: Poulet, Boeuf (Vache), Chien, Humain, Souris, Porc, Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human beta-Amyloid 1-40

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P)(1:100-500)
Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur Abeta 1-40

Antigène: Abeta 1-40 (Amyloid beta 1-40 (Abeta 1-40))

Autre désignation: beta-Amyloid 1-40 (Abeta 1-40 Produits)

Synonymes: anticorps AAA, anticorps ABETA, anticorps ABPP, anticorps AD1, anticorps APPI, anticorps CTFgamma, anticorps CVAP, anticorps PN-II, anticorps PN2, anticorps amyloid beta precursor protein, anticorps APP

Sujet:

Synonyms: beta Amyloid1-40, beta Amyloid 1-40, beta-Amyloid 1-40, Amyloid 1-40, P340, A4, AAA, ABETA, ABPP, AD1, Alzheimers Disease Amyloid Protein, Amyloid B, Amyloid Beta A4 Protein Precursor, Amyloid Beta, Amyloid of Aging and Alzheimer Disease, APP, APPI, B Amyloid, Beta APP, Cerebral Vascular Amyloid Peptide, CTFgamma, CVAP, PN II, PN2, PreA4, Protease nexin II, A beta, A4_HUMAN.

Background: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.

Poids moléculaire: 4.3kDa

ID gène: 351